GLOBAL STEM CELLS GROUP ANNOUNCES THE LAUNCH OF ITS NEW DIVISION “VITA NOVAS”
A Step towards the Actualization of Regenerative Medicine
The Global Stem Cells Group takes another luminary step by launching its new company VITA NOVAS in the field of Regenerative medicine. Vita Novas is a mobile IV infusion company that provides in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases. Under the banner of GSCG, Vita Novas is ready to launch in 26 countries in the first year of its inception.
Having the cushion of an already established worldwide network and 10 years of experience of GSCG, VITA NOVAS has already gained ground with the inherited reputation of quality, innovation, and professionalism. The VITA NOVAS’ program delivers micronutrients and stimulating biological products like Exosomes and Mesenchymal Stem Cells intravenously, guaranteeing an effective way for the ingredients to become immediately available to the cells. This greatly decreases the time it takes for the medication or supplements to take effect. Patient-centred carved out packages The Shield, the Fighter, and the Lightening are delivered on-demand to homes, offices, or hotels administered by certified healthcare professionals.
Believing on the percept of Prevent-Protect-Thrive, VITA NOVAS aspires to set standards in the industry, and committed to ensure in-home, and personalized patient service; keeping them away from hospitals and emergencies. VITA NOVAS offers infusion packages, mixed with essential fluids, electrolytes, vitamins, and antioxidants as a powerful cocktail to stimulate the immune system and help bolster it to assist in fighting infections and diseases. In-line with the evolved life pattern of social distancing, the process of treatment at VITA NOVAS culminates as:
Select your Service Area
Schedule a video consultation with our local doctors to discuss your possible treatment plan
Receive the treatment at home
“We have combined elements of Tele-health with cellular therapy, IV wellness infusions, and a direct-to-consumer model intending to capitalize on the burgeoning market for medical services at the patient’s’ place of residence, due to convenience and social distancing practices,” explains Benito Novas , CEO of VITA NOVAS.
The secret behind the VITA NOVAS program is the provision of assistance and prime incentives to medical professionals. Once a physician joins the network, the company provides training and support that they will need in order to set-up run, and market their practices. They enjoy geography and specialization exclusively as well as a strong network of patients referrals, increased revenues, and conduct consultations from home.
Global Stem Cells Group, with golden track record and experience of a decade, is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2010 by Benito Novas, the company combines dedicated researchers, physicians, patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading-edge Regenerative Medicine treatments. Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art regenerative technology, while adhering to the highest medical standards.
VITA NOVAS can help, to find your service area, please visit: www.vitanovas.net
To know more about the company , visit www.stemcellsgroup.com
- Published in Press Releases
ISSCA to Conduct First Hands On Regenerative Medicine Training after Global Pandemic
he COVID19 pandemic has brought about a ‘new normal’ of social-distancing, closed businesses and self-isolation. After several months of inactivity brought about by this virus and the period of self-isolation, the International Society for Stem Cell Application is ready to begin the process of resuming our schedule of training courses,
Florida (PRUnderground) May 19th, 2020
Now, more than ever, interest in the immune system and its health has breached our collective consciousness, both phycicians and scientist are turning to regenerative medicine as a way to strengthen it. Recent breakthroughs in the field have led to a newly devised program– one with a proprietary protocol for strengthening the immune system, furthering a person’s ability to fight and prevent disease.
This inaugural training will take place in Washington over the course of two days, during which we will be training a group of five doctors in the latest regenerative medicine techniques. We will go over our traditional program providing physicians with all of the tools they will need to begin incorporating regenerative medicine into their own practice
The International Society for Stem Cell Application is an independent, non-profit organization whose objective is to become the gold standard of regenerative medicine. It accomplishes this through hosting conferences and specialized certification courses, publishing and sharing clinical research, and setting protocols in the field of regenerative medicine. Through this partnership, we are seeking to spread knowledge on the current applications of cellular therapies by building a platform for doctors to discuss and debate the newest advancements in the field. These conferences have been held in dozens of countries, and work to create a global network of regenerative medicine researchers and practitioners.
If you’d like to know more information about our program, or the courses that we offer around the world, please check out by visiting our website at: www.issca.us
About International Society for Stem Cells Applications
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com
- Published in Press Releases
GLOBAL STEM CELLS GROUP will host ISSCA Regenerative Medicine Training
After several months of silence due to the mandatory shutdown in place, the training division of Global Stem Cells Group –known as ISSCA Training– has officially announced the reopening of its regularly scheduled training dates Around the world
Miami, FL (PRUnderground) May 20th, 2020
“The future’s looking bright for our Regenerative MedicineTraining program, we’ve taken our course and updated it, reinforcing it with new information and quality protocols that’ll help doctors and their patients manage this ‘new normal’ as well as they can, and we’re very excited to be able to be bringing this new information to physicians around the world– but we’ve decided to start small for now, with the reinstatement of our headquarters’ operations,” — Benito Novas, CEO
Because of the growing interest in the industry , ISSCA Regenerative MedicineTraining has updated its program with new protocols focused on the optimization of the body at the cellular level. Notably, their upcoming June course will also include live practice patients in the treatments of autologous cell therapy, which includes PRP, adipose-derived stem cells, bone-marrow derived stem cells, exosomes, Umbilical Cord Blood Cells, and other novel techniques.
Stem Cell Training is a company that seeks to instruct medical professionals around the world on regenerative medicine techniques. They do this by sharing breakthrough scientific research on stem cell therapy and treatment, as well as developing and offering courses, seminars, and workshops based on this research.
About the Global Stem Cells Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2010, the company combines dedicated researchers, physicians ,patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge Regenerative Medicine treatments.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art regenerative technology
- Published in Press Releases
Global Stem Cells Group Announces Launch of Vita Novas In-Home IV Infusion Service
Its no secret that a quality IV infusion can boost health and energy. Vita Novas makes this more simple than ever performing IV services than revitalize the body and help it regenerate, right at home.
Miami , Florida (PRUnderground) May 20th, 2020
The interest in boosting the immune system in a safe and effective way is a topic on more minds than ever. In exciting news, Global Stems Group has announced the launch of a new company, Vita Novas who make this both simple and dependable. Vita Novas offers an IV infusion packages are a mix of stem cells, essential fluids, electrolytes, vitamins and antioxidants as a preventive solution for having an optimal immune system. This IV infusion is delivered at home, in an office, or at a hotel, by certified healthcare professionals. With the global pandemic shutting doors of physicians for elective and health-enhancing non-vital procedures going to get IV treatments in most communities is difficult, if not impossible. Vita Novas is opening the doors for these life-enhancing treatments to be accesses in an easy and convenient way.
“The demand for preventive health services using IV infusion is greater than ever,” commented Benito Novas, CEO of the company. “What we are doing, by offering these at home and offices, is not just making things more convenient but also following social distancing requirements. Its truly making the right thing available at the right time and place.”
Vita Novas provides a teleconsultation with a Doctor to determine what meets a patient’s needs best. Three different vitamin and nutrient vitamin infusion packages are available.
The Lighting Package consists of two sessions of IV administration of vitamins (Vitamin C, B-Complex vitamins, and trace minerals), with a patient follow up recommending dietary changes and oral supplements to maintain good health.
The Shield Package is three sessions of IV administered (high dose Vitamin C, Methylcobalamin, Zinc sulphate, Glutathione and five billion flow exosomes). This has been shown have a powerful effect in regulating regenerative processes in the body and increase cell to cell communication. This has been used to treat COVID-19 patients with exciting results, something clearly at the front of people’s minds of all ages and lifestyles.
The Fighter Packages is the platinum offer from Vita Novas. This combines IV administration of high dose micronutrients (amino acids, glutathione), vitamins (B-Complex, methylcobalamin, Folic Acid, Vitamin C), and trace minerals (zinc, copper, magnesium) along with 30 million live stem cells in 5 sessions. This can modulate immunity and assist in the regeneration process of damaged or infected tissue in a very dramatic way.
Vita Novas is currently positioned to be able to launch the program in ten different countries with the number rising to over 25 within six months. The near and far future are bright for the company and its potentially life-changing services.
About the Global Stem Cells Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2010, the company combines dedicated researchers, physicians ,patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge Regenerative Medicine treatments.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art regenerative technology
- Published in Press Releases
Global Stem Cells Group’s Benito Novas named Dr. Honoris Causa
CES University of Medellín, Colombia bestowed the honor upon Novas due to his exemplary work in marketing and the regenerative medicine field
MIAMI LAKES, Florida—Benito Novas, Vice President of The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has been awarded the degree of Dr. Honoris Causa from CES University in Medellín. The award comes in recognition of his work as a global leader in marketing and as a key figure in the regenerative medicine field.
For the past 15 years, Novas has worked as a marketing professional and is a recognized leader in the industry. Novas created a specific marketing model that has proven to be successful for private medical institutions to gain industry recognition and grow into thriving organizations. He is a sought-after speaker and has been an invited guest and keynote speaker at a number of medical congresses across the globe, sharing his latest marketing strategies with medical institutions looking to recruit new patients.
Novas has also played an integral role in the regenerative medicine field as a business owner. His contributions to the field are noteworthy and include organizing various congresses and certification courses across five continents. His holding, the Global Stem Cells Group, has worked to increase access to affordable equipment and regenerative medicine supplies to doctors across the world. His foundation has provided hundreds of free regenerative medicine treatments in each country where he has visited.
“It is an honor to have such a prestigious award bestowed upon me” said Novas. “I am grateful to the administration at CES University for considering me for this award.”
To learn more about CES University, visit https://www.ces.edu.co. To learn more about ISSCA and Benito Novas, visit https://issca.us/.
- Published in Press Releases
Global Stem Cells Group Set to Sponsor Cancun Medical Congress
Global Stem Cells’ group affiliate Adimarket set to launch new products during the international event.
MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, will host a two-day medical congress in Cancun, Mexico. The 7 Congreso Internacional de Terapias Avanzadas en Medicina will take place on December 7-8, 2019 and will feature speakers from various countries, including the United States, Argentina, Mexico, and Colombia.
Congress organizers expect over 250 Mexican doctors will attend the event, which will feature a variety of experts in the field of regenerative medicine and cutting-edge products in the industry that are designed to help treat patients suffering from degenerative diseases.
Adimarket, the largest online regenerative medicine store and a subsidiary of the Global Stem Cells Group, will be on hand to launch its newest allogeneic stem cells products during the event. These heterologous compounds were developed exclusively for a LATAM market, striking a balance between a high-quality treatment option and an affordable price. Products currently offered by Adimarket in this category include exosomes, cord blood derived stem cells, and stem cells derived from amniotic fluid.
All of Adimarket’s products are designed to help provide safe and effective treatment options to doctors treating patients suffering from degenerative diseases.
To learn more about Adimarket and all of its regenerative medicine solutions, visit https://www.adimarket.net/. To learn more about ISSCA and all of their upcoming and past events, visit https://issca.us/.
- Published in Press Releases
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has signed an agreement with European-based Clinica Planas to offer a stem cells certification training program. The first event will be held in Barcelona on October 18-19, 2019.
“The Global Stem Cells Group is pleased to partner with Clinica Planas to offer this important certification in cell therapies,” said Benito Novas, Vice President of the Global Stem Cells Group. “This partnership will continue our mission to help provide knowledge of regenerative medicine practices and treatment options to physicians across the globe.”
Clinica Planas has two locations in Spain—Barcelona and Madrid—and is known as one of the most prestigious medical centers in Europe. In this new deal, Clinical Planas will partner with the Global Stem Cells Group to help train European-based physicians in the regenerative medicine industry’s best practices and most up-to-date knowledge.
The inaugural certification workshop will be held on October 11-12 in Barcelona, with additional certification opportunities to be offered on an ongoing basis in the future. During the two-day event, physicians will receive insight on 22 proprietary treatment protocols to treat degenerative diseases, acquire skills to be able to offer alternative treatment options to patients who have yet to try regenerative medicine as an option, and join an exclusive network of doctors at the forefront of medical science.
“Our goal is to help physicians looking for new treatment options for their patients suffering from degenerative diseases gain the necessary skills to be able to offer regenerative treatments as an option to alleviate their patients’ suffering,” Novas noted.
To learn more about the October 2019 certification event in Barcelona, visit http://cursocelulasmadre.com/entrenamiento-en-barcelona/.
To learn more about Clinica Planas, visit https://www.clinicaplanas.com/en. To learn more about ISSCA and all of their upcoming and past events, visit https://issca.us/.
- Published in Press Releases
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group
MIAMI LAKES, FL, May 30, 2019-Global Stem Cells Group Inc. (GSCG) is pleased to announce that it has entered into a binding letter of intent to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
GSCG operates in the global stem cell market which is forecasted by Transparency Market Research to reach $270 billion dollars by 2025 of which roughly 40% or $100 billion will be derived from outside of North America and growing at a 13.8% compounded annual growth rate.
GSCG specializes in leading-edge stem cell research, patient application and physician training. The company licenses its name and intellectual property to physicians around the world and supplies them with necessary equipment and medical supplies to perform stem cell treatments. The company currently has one of the largest member clinic networks in the world spanning over 25 countries.
“We are very pleased to have entered into this binding LOI with Global Stem Cells Group,” said Dave Christensen, CEO of Lans Holdings Inc. “This transaction represents a significant opportunity for our company to enter the explosive field of Stem Cell technology with a proven and seasoned team and I look forward to working closely with GSCG to execute on their growth plans.”
“We are excited to join forces with Lans Holdings,” said Benito Novas, President and CEO of Global Stem Cells Group. “This union will allow us to have access to the capital markets to further fuel our growth as the global stem cells market enters into an accelerated expansion phase.”
- Published in Press Releases
Benito Novas, Global Stem Cells Group CEO, Slated to Give Keynote Speech.
Novas is a global expert on medical practice marketing strategies, specifically those pertaining to regenerative medicine.
MIAMI LAKES, Florida—Benito Novas, CEO of the Global Stem Cells Group, will serve as the keynote speaker at an event sponsored by the International Society for Stem Cell Application held in Mexico City on May 3-4, 2019. Novas is known as a global experts on medical practice marketing strategies, specifically those pertaining to the regenerative medicine field.
The Mexico City Stem Cells Seminar is a two-day medical congress and the first of its kind to offer an entire day focused on medical marketing. Novas will serve as both a keynote speaker and also as a marketing professional to offer his expertise during this portion of the congress.
As the CEO of the Global Stem Cells Group, Benito Novas is an entrepreneur and leader of an international enterprise that provides complete services to the regenerative medicine industry. Though his work, he has created programs that provide Stem Cells Certification opportunities for practitioners in the field in addition to supporting stem cells medical research efforts across the globe.
Benito Novas is known as a global expert on research marketing strategies, especially pertaining to the realm of regenerative medicine. He has extensively researched marketing strategies that are proven to grow medical practices worldwide, including those in the US. Putting his research to use, Novas has successfully grown regenerative medical practices across the globe.
In addition to his personal research pursuits, Benito Novas frequently lends his expertise as a marketing expert to private medical practices and other groups worldwide. He has also conducted medical business in various countries across South America and the Middle East.
To learn more about Benito Novas, visit his LinkedIn profile at https://bit.ly/2IMgGtJ.
- Published in Press Releases
